Beta interferons in clinically isolated syndromes: a meta-analysis Interferons beta nas síndromes clínicas isoladas: meta-análise

by Ailton Melo, Bernardo Rodrigues, Amit Bar-Or
Published 2008-03-01

Editorial: Update on Translational Neuroimmunology - Research of ISNI 2018

by Lesley Probert, Francisco J. Quintana, Amit Bar-Or
Published 2020-09-01

Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis

by Peter J. Darlington, Brandon Stopnicki, Tarik Touil, Jean-Sebastien Doucet, Lama Fawaz, Morgan E. Roberts, Marie-Noëlle Boivin, Marie-Noëlle Boivin, Nathalie Arbour, Mark S. Freedman, Harold L. Atkins, Amit Bar-Or, Amit Bar-Or
Published 2018-05-01

Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE

by Ralf Gold, Douglas L. Arnold, Amit Bar-Or, Robert J. Fox, Ludwig Kappos, Chongshu Chen, Becky Parks, Catherine Miller
Published 2020-05-01

Effects of blood transportation on human peripheral mononuclear cell yield, phenotype and function: implications for immune cell biobanking.

by Anita Posevitz-Fejfár, Vilmos Posevitz, Catharina C Gross, Urvashi Bhatia, Frank Kurth, Verena Schütte, Amit Bar-Or, Sven G Meuth, Heinz Wiendl
Published 2014-01-01

Deep learning segmentation of orbital fat to calibrate conventional MRI for longitudinal studies

by Robert A. Brown, Dumitru Fetco, Robert Fratila, Giulia Fadda, Shangge Jiang, Nuha M. Alkhawajah, E. Ann Yeh, Brenda Banwell, Amit Bar-Or, Douglas L. Arnold
Published 2020-03-01

High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study.

by Ruth Ann Marrie, Julia O'Mahony, Colleen J Maxwell, Vicki Ling, E Ann Yeh, Douglas L Arnold, Amit Bar-Or, Brenda Banwell, Canadian Pediatric Demyelinating Disease Network
Published 2019-01-01

Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis

by Hanane Touil, Antonia Kobert, Nathalie Lebeurrier, Aja Rieger, Philippe Saikali, Caroline Lambert, Lama Fawaz, Craig S. Moore, Alexandre Prat, Jennifer Gommerman, Jack P. Antel, Yasuto Itoyama, Ichiro Nakashima, Amit Bar-Or, for the Canadian B Cell Team in MS
Published 2018-04-01

Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.

by Deepak K Kaushik, Heather Y F Yong, Jennifer N Hahn, Claudia Silva, Steven Casha, R John Hurlbert, Francois H Jacques, Robert Lisak, Omar Khan, Carolina Ionete, Catherine Larochelle, Alex Prat, Amit Bar-Or, V Wee Yong
Published 2016-01-01

Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis

by Simon Thebault, Hyunwoo Lee, Gauruv Bose, Daniel Tessier, Mohammad Abdoli, Marjorie Bowman, Jason Berard, Lisa Walker, Carolina A. Rush, Heather MacLean, Ronald A. Booth, Sridar Narayanan, Douglas L. Arnold, Vincent Tabard‐Cossa, Harold L. Atkins, Amit Bar‐Or, Mark S. Freedman
Published 2020-05-01

A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected].

by Yusei Miyazaki, Rui Li, Ayman Rezk, Hétoum Misirliyan, Craig Moore, Nasr Farooqi, Mayra Solis, Lorna Galleguillos Goiry, Omar de Faria Junior, Van Duc Dang, David Colman, Ajit Singh Dhaunchak, Jack Antel, Jennifer Gommerman, Alexandre Prat, Simon Fillatreau, Amit Bar-Or, CIHR/MSSC New Emerging Team Grant in Clinical Autoimmunity, MSSRF Canadian B cells in MS Team
Published 2014-01-01

Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS

by Ramona Gerhards, Lena Kristina Pfeffer, Jessica Lorenz, Laura Starost, Luise Nowack, Franziska S. Thaler, Miriam Schlüter, Heike Rübsamen, Caterina Macrini, Stephan Winklmeier, Simone Mader, Mattias Bronge, Hans Grönlund, Regina Feederle, Hung-En Hsia, Stefan F. Lichtenthaler, Juliane Merl-Pham, Stefanie M. Hauck, Tanja Kuhlmann, Isabel J. Bauer, Eduardo Beltran, Lisa Ann Gerdes, Aleksandra Mezydlo, Amit Bar-Or, Brenda Banwell, Mohsen Khademi, Tomas Olsson, Reinhard Hohlfeld, Hans Lassmann, Tania Kümpfel, Naoto Kawakami, Edgar Meinl
Published 2020-11-01

Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases

by Seth N. Levin, Shruthi Venkatesh, Katie E. Nelson, Yi Li, Ines Aguerre, Wen Zhu, Karman Masown, Kathryn T. Rimmer, Claudiu I. Diaconu, Kaho B. Onomichi, Victoria M. Leavitt, Libby L. Levine, Rebecca Strauss‐Farber, Wendy S. Vargas, Brenda Banwell, Amit Bar‐Or, Joseph R. Berger, Andrew D. Goodman, Erin E. Longbrake, Jiwon Oh, Bianca Weinstock‐Guttman, Kiran T. Thakur, Keith R. Edwards, Claire S. Riley, Zongqi Xia, Philip L. De Jager, Multiple Sclerosis Resilience to COVID‐19 (MSReCOV) Collaborative
Published 2021-04-01

Toll-like receptor modulation of disease relevant B cell responses

by Rieger, Aja
Published 2009

Characterization of differentially activated human B cells and effects of their soluble products on regulatory T cell suppressive function: assay development and design

by Lawrie, Sarah
Published 2012

CNS-resident cells support MS-relevant B-cell responses

by Kobert, Antonia
Published 2013

Novel findings on the impact of HIV infection: Interplay between T cell development and peripheral T cell homeostasis

by Zeidan, Joumana
Published 2011

Dual agonist-antagonist functions of FTY720 influence neuroinflammation-relevant responses in human astrocytes

by Wu, Celina
Published 2012